Roche announced today the U.S. introduction of the cobas b 123 POC system, a mobile blood gas analyzer designed for hospital point of care settings. The system’s next-generation technology helps ensure reliable performance by virtually eliminating the introduction of blood clots that can contribute to analyzer downtime and negatively impact patient care.
To view Multimedia News Release, go to https://www.multivu.com/mnr/57116-roche-cobas-b-123-poc-system-mobile-blood-gas-analyzer-hospital-technology
Cursed Mountain on the Nintendo Wii, the most frightening game you will find on any console. These are real people who dared to take on the game. http://cursedmountain.deepsilver.com
Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
Get in on the blood soaking action. It's real blood! Your Blood! It's the hottest new toy! It's awesome... Totally! Plasma Blaster 3000. www.PB3000.com
During the Academy of Nutrition and Dietetics 2017 Food & Nutrition Conference & Expo™ in Chicago, scientists reported on a recent study which uncovered that the intake of pistachios reduces the rise in blood sugar and insulin in women diagnosed with gestational diabetes mellitus (GDM)—commonly known as gestational diabetes. The study, “Effects of Pistachio Intake on Postprandial Blood Glucose Response in Pregnant Women,” found when women who were gestational glucose intolerant (GIGT) or who were diagnosed with GDM ate pistachios, they had a significantly lower rise in blood glucose levels compared to eating whole wheat bread that was matched for calories.
To view the multimedia release go to:
https://www.multivu.com/players/English/8162751-american-pistachio-growers-pistachio-health-benefits-women-gestational-diabetes/
OneTouch®, a leading brand of blood glucose monitoring systems for people with diabetes, has introduced Life First™, a new North American campaign featuring music legend B.B. King and Crystal Bowersox, one of music’s most talented new artists. The ads debut on national and regional television today and will be followed by online and print ads over the next several months. The introduction of the campaign is particularly timely, since March 22 marks National Diabetes Alert Day in the U.S.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/onetouch/48943/
Close-Up TV News recognizes the NYU Langone Weight Management Program as the country’s premier surgical weight loss facility
The term “morbid obesity” is generally defined as being 100 lbs over the ideal weight or having a Body Mass Index between 35 and 40. Morbid obesity significantly can increase a patient’s risk for diabetes, heart disease and high blood pressure. Unfortunately, for these patients, diet and exercise alone cannot offer a practical solution.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/thinforlife/50245/
Novo Nordisk, a world leader in diabetes care, today kicked off the first NovoLog® Community Star contest. As part of the program, type 2 diabetes patients successfully managing their blood sugar with NovoLog® (insulin aspart [rDNA origin] injection) are invited to visit www.novolog.com and tell us how they’re giving back to their local communities.
Now through March 15, NovoLog® patients can submit their story and photo online for the chance to be crowned a NovoLog® Community Star. Finalists will be selected by a panel of judges, and each will receive a $5,000 donation to a local diabetes-related organization of their choice. One grand prize winner will also receive a one-year online subscription to Weight Watchers® to help with their diabetes management.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59947-novo-nordisk-first-novolog-community-star-contest-type-2-diabetes-patients
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
Master of Koga Ryu Ninjutsu mr Sensei Titus Mathijn Jansen is demonstrating here the sword skills of the Koga Ninja. Sword is sometimes a difficult weapon and you need a lot of training to become good at it. Check this demonstration of Koga Ryu Ninjutsu by the founder of the Kage Ryu Dojo Sensei Titus Jansen.
